You see a filtered list - Keywords: Trebicka-Selection
[1]R. Schierwagen, C. Alvarez-Silva, M. S. A. Madsen, C. C. Kolbe, C. Meyer, D. Thomas, F. E. Uschner, F. Magdaleno, C. Jansen, A. Pohlmann, M. Praktiknjo, G. T. Hischebeth, E. Molitor, E. Latz, B. Lelouvier, J. Trebicka, M. Arumugam,
"Circulating microbiome in blood of different circulatory compartments", Gut, vol. 68, no. 3, 2018, pp. 578–580.
[bibtex] [url] [doi]
[2]J. Trebicka, M. von Heydebrand, J. Lehmann, F. Tofteng, T. Busk, H. L. Jensen, J. Rohde, T. Reiberger, C. Mortensen, R. Schierwagen, S. Klein, S. M{ø}ller, F. Bendtsen, A. Krag,
"Assessment of response to beta-blockers by expression of $\upbeta$Arr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients", Journal of Hepatology, vol. 64, no. 6, 2016, pp. 1265–1273.
[bibtex] [url] [doi]
[3]M. Berres, J. Lehmann, C. Jansen, J. Görtzen, C. Meyer, D. Thomas, H. W. Zimmermann, D. C. Kroy, F. Schumacher, C. P. Strassburg, T. Sauerbruch, C. Trautwein, H. E. Wasmuth, J. Trebicka,
"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt", Liver international, vol. 36, no. 3, 2016, pp. 386–394.
[bibtex] [url] [doi]
[4]S. Klein, J. Rick, J. Lehmann, R. Schierwagen, I. G. Schierwagen, L. Verbeke, K. Hittatiya, F. E. Uschner, S. Manekeller, C. P. Strassburg, K. Wagner, P. P. Sayeski, D. Wolf, W. Laleman, T. Sauerbruch, J. Trebicka,
"Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis", Gut, vol. 66, no. 1, 2015, pp. 145–155.
[bibtex] [url] [doi]
[5]M. Berres, J. Lehmann, C. Jansen, J. Görtzen, C. Meyer, D. Thomas, H. W. Zimmermann, D. Kroy, F. Schumacher, C. P. Strassburg, T. Sauerbruch, C. Trautwein, H. E. Wasmuth, J. Trebicka,
"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt", Liver International, vol. 36, no. 3, 2015, pp. 386–394.
[bibtex] [url] [doi]
[6]M. Granzow, R. Schierwagen, S. Klein, B. Kowallick, S. Huss, M. Linhart, I. G. R. Mazar, J. Görtzen, A. Vogt, F. A. Schildberg, M. A. Gonzalez-Carmona, A. Wojtalla, B. Krämer, J. Nattermann, S. V. Siegmund, N. Werner, D. O. Fürst, W. Laleman, P. Knolle, V. H. Shah, T. Sauerbruch, J. Trebicka,
"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis", Hepatology, vol. 60, no. 1, 2014, pp. 334–348.
[bibtex] [url] [doi]
[7]E. Anadol, R. Schierwagen, N. Elfimova, K. Tack, C. Schwarze-Zander, H. Eischeid, A. Noetel, C. Boesecke, C. Jansen, L. Dold, J. Wasmuth, C. P. Strassburg, U. Spengler, J. K. Rockstroh, M. Odenthal, J. Trebicka,
"Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients", Hepatology, vol. 61, no. 1, 2014, pp. 46–55.
[bibtex] [url] [doi]
[8]J. Trebicka, E. Anadol, N. Elfimova, I. Strack, M. Roggendorf, S. Viazov, I. Wedemeyer, U. Drebber, J. Rockstroh, T. Sauerbruch, H. Dienes, M. Odenthal,
"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis", Journal of Hepatology, vol. 58, no. 2, 2013, pp. 234–239.
[bibtex] [url] [doi]
[9]J. A. Grace, S. Klein, C. B. Herath, M. Granzow, R. Schierwagen, N. Masing, T. Walther, T. Sauerbruch, L. M. Burrell, P. W. Angus, J. Trebicka,
"Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis", Gastroenterology, vol. 145, no. 4, 2013, pp. 874–884.e5.
[bibtex] [url] [doi]
[10]S. Klein, M. M. V. Beuge, M. Granzow, L. Beljaars, R. Schierwagen, S. Kilic, I. Heidari, S. Huss, T. Sauerbruch, K. Poelstra, J. Trebicka,
"HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects", Journal of Hepatology, vol. 57, no. 6, 2012, pp. 1220–1227.
[bibtex] [url] [doi]